75/m mit febriler Neutropenie unter Chemotherapie
Authors:
- 23 January 2026
- journal article
- training zusatz-weiterbildung
- Published by Springer Nature in Medizinische Klinik - Intensivmedizin und Notfallmedizin
- Vol. 121 (S1) , 144-149
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Impact of COVID-19 on immunocompromised populations during the Omicron era: insights from the observational population-based INFORM studyThe Lancet Regional Health - Europe, 2023
- Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021Intensive Care Medicine, 2021
- Der Krebspatient auf der IntensivstationMedizinische Klinik - Intensivmedizin und Notfallmedizin, 2021
- Management of sepsis in neutropenic cancer patients: 2018 guidelines from the Infectious Diseases Working Party (AGIHO) and Intensive Care Working Party (iCHOP) of the German Society of Hematology and Medical Oncology (DGHO)Annals of Hematology, 2019
- Low Levels of Procalcitonin or Presepsin Combined with Significantly Elevated C‐reactive Protein May Suggest an Invasive Fungal Infection in Hematological Patients With Febrile NeutropeniaHemaSphere, 2019
- Neutropenie und SepsisDie Innere Medizin, 2013
- A prospective survey of febrile events in hematological malignanciesAnnals of Hematology, 2011
- Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of AmericaClinical Infectious Diseases, 2011